Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations
- PMID: 30547319
- DOI: 10.1007/s00417-018-04209-7
Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations
Abstract
Interferons are cytokines that regulate the host's response to viral infection, particularly in the setting of the immunologic response to the hepatitis C virus (HCV). While the virus has the ability to evade the host's innate and specific immunity, exogenous interferon-α with combined ribavirin, treatments have been found to achieve a significant sustained viral response in subgroups of patients with chronic HCV. One of the major side effects of interferon-α is an ocular retinopathy characterized by flame-shaped hemorrhages and cotton wool spots visualized on funduscopic examination. There have been documented cases of more severe side effects including optic nerve and retinal artery damage; however, these instances are the minority. We sought to investigate the literature surrounding interferon-induced retinopathy, clinically correlate our findings with two recent cases, and provide recommendations for practitioners who continue to manage chronic HCV patients using interferon-α with combined ribavirin treatments.
Keywords: Fundoscopic imaging; Hepatitis C; Interferon; Macular edema; Neuropathy; Ocular toxicity; Optical coherence tomography; Retinopathy.
Similar articles
-
Retinopathy in chronic hepatitis C patients during interferon treatment: a case report.Infez Med. 2010 Dec;18(4):267-9. Infez Med. 2010. PMID: 21196822
-
Hepatitis C: a review of diagnosis, management, and ocular complications from treatment.Optometry. 2003 Aug;74(8):517-23. Optometry. 2003. PMID: 12926825
-
Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.Ophthalmology. 2003 Feb;110(2):437-42. doi: 10.1016/S0161-6420(02)01741-4. Ophthalmology. 2003. PMID: 12578794
-
[Bilateral non-arteritic ischemic optic neuropathy during treatment of viral hepatitis C with pegylated interferon and Ribavirin].J Fr Ophtalmol. 2015 Jan;38(1):34-40. doi: 10.1016/j.jfo.2014.06.008. Epub 2014 Dec 18. J Fr Ophtalmol. 2015. PMID: 25533994 Review. French.
-
[Interferon dysoric retinopathy in chronic viral hepatitis C: case report and literature review].Rev Med Interne. 2014 Aug;35(8):543-5. doi: 10.1016/j.revmed.2013.10.005. Epub 2013 Oct 31. Rev Med Interne. 2014. PMID: 24182682 Review. French.
Cited by
-
Combined Branch Retinal Artery and Central Retinal Vein Occlusion: A Systematic Review.Vision (Basel). 2023 Jul 28;7(3):51. doi: 10.3390/vision7030051. Vision (Basel). 2023. PMID: 37606497 Free PMC article. Review.
-
Unilateral retinopathy post perilesional interferon α2b injections for ocular surface squamous cell carcinoma.Am J Ophthalmol Case Rep. 2021 Aug 27;24:101196. doi: 10.1016/j.ajoc.2021.101196. eCollection 2021 Dec. Am J Ophthalmol Case Rep. 2021. PMID: 34485759 Free PMC article.
-
Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects.Acta Derm Venereol. 2022 May 24;102:adv00722. doi: 10.2340/actadv.v102.2487. Acta Derm Venereol. 2022. PMID: 35506362 Free PMC article. No abstract available.
-
Could Infectious Agents Play a Role in the Onset of Age-related Macular Degeneration? A Scoping Review.Ophthalmol Sci. 2024 Nov 30;5(2):100668. doi: 10.1016/j.xops.2024.100668. eCollection 2025 Mar-Apr. Ophthalmol Sci. 2024. PMID: 39906411 Free PMC article. Review.
-
Ocular side effects of antirheumatic medications: a qualitative review.BMJ Open Ophthalmol. 2020 Jan 7;5(1):e000331. doi: 10.1136/bmjophth-2019-000331. eCollection 2020. BMJ Open Ophthalmol. 2020. PMID: 32154367 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical